133
Participants
Start Date
December 13, 2017
Primary Completion Date
November 9, 2018
Study Completion Date
November 9, 2018
MEDI5884
Participants will receive SC dose of MEDI5884 50 mg or 100 mg or 200 mg or 350 mg or 500 mg on Days 1, 31, and 61.
Placebo
Participants will receive SC dose of placebo (volume matched to MEDI5884) on Days 1, 31, and 61.
Research Site, Savannah
Research Site, Fleming Island
Research Site, Port Orange
Research Site, Jacksonville
Research Site, Pembroke Pines
Research Site, Huntsville
Research Site, Anniston
Research Site, Kingsport
Research Site, Louisville
Research Site, Marion
Research Site, Stow
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, Rapid City
Research Site, Fargo
Research Site, Evanston
Research Site, Oklahoma City
Research Site, San Antonio
Research Site, McAllen
Research Site, Northridge
Research Site, El Cajon
Research Site, Lincoln
Research Site, Waterbury
Lead Sponsor
MedImmune LLC
INDUSTRY